SARA RHOTEN: Open Payments
NPI 1831637362 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$559 in 5 payments from 5 companies in 2025. Trend: 2023 $1,171 · 2024 $799 · 2025 $559
Food & beverage: $559
| Company | Payments | Amount |
|---|---|---|
| Apellis Pharmaceuticals, Inc. | 1 | $292 |
| Calliditas Therapeutics US Inc. | 1 | $125 |
| AKEBIA THERAPEUTICS INC | 1 | $105 |
| Aurinia Pharma U.S., Inc. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: TARPEYO, Vafseo, LUPKYNIS, BENLYSTA.
Industry payments across OH — which companies pay providers there.
